ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,405,826 | -13.3% | 78,319 | -1.9% | 0.00% | – |
| Q2 2023 | $1,620,738 | -83.5% | 79,800 | -85.2% | 0.00% | -100.0% |
| Q1 2023 | $9,850,000 | +92405.6% | 539,995 | +4.9% | 0.00% | 0.0% |
| Q4 2022 | $10,648 | -99.9% | 514,911 | +2.2% | 0.00% | -50.0% |
| Q3 2022 | $13,177,000 | +0.5% | 503,733 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $13,105,000 | -4.7% | 517,192 | +18.7% | 0.00% | 0.0% |
| Q1 2022 | $13,753,000 | +26.6% | 435,793 | +62.4% | 0.00% | +100.0% |
| Q4 2021 | $10,863,000 | +15.7% | 268,412 | -0.4% | 0.00% | 0.0% |
| Q3 2021 | $9,392,000 | +24.9% | 269,359 | -1.6% | 0.00% | 0.0% |
| Q2 2021 | $7,517,000 | -29.2% | 273,733 | -27.6% | 0.00% | 0.0% |
| Q1 2021 | $10,615,000 | -17.7% | 378,023 | -24.0% | 0.00% | -50.0% |
| Q4 2020 | $12,905,000 | +68.5% | 497,142 | +13.0% | 0.00% | +100.0% |
| Q3 2020 | $7,658,000 | -24.7% | 439,858 | +7.0% | 0.00% | -50.0% |
| Q2 2020 | $10,169,000 | +88.8% | 411,049 | +5.9% | 0.00% | +100.0% |
| Q1 2020 | $5,386,000 | +13.9% | 388,064 | -17.1% | 0.00% | 0.0% |
| Q4 2019 | $4,730,000 | +1.6% | 468,364 | -8.4% | 0.00% | 0.0% |
| Q3 2019 | $4,654,000 | +16.8% | 511,364 | -0.8% | 0.00% | 0.0% |
| Q2 2019 | $3,983,000 | -34.7% | 515,262 | +5.5% | 0.00% | 0.0% |
| Q1 2019 | $6,102,000 | +15.0% | 488,553 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $5,308,000 | -19.3% | 492,813 | +4.4% | 0.00% | 0.0% |
| Q3 2018 | $6,581,000 | +109.6% | 472,072 | +84.0% | 0.00% | 0.0% |
| Q2 2018 | $3,140,000 | +18370.6% | 256,538 | +23221.6% | 0.00% | – |
| Q1 2018 | $17,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |